Technical Writing for the Pharmaceutical Manufacturing Industry

The Pharmaceutical manufacturing industry is a very different industry, it is not a study in creative writing. It is an industry that is based on providing fact-based evidence and developing a sound scientific conclusion based on that evidence. Understanding how to write for the industry is an art, there are few courses that teach how to write for the industry. It is mostly up to the writer to develop a style and technique that is appropriate for the industry. This course is not an extensive writing course, but an introduction into the documents, various formats, and how to develop the writing component that is needed for the Pharmaceutical Manufacturing industry.Various example documents will be discussed: Investigations (deviations and other quality system documents), facility reports, environmental monitoring reports, validation reports, validation protocols, etc. 
In this webinar expert speaker Carl Patterson will provide how to organize and deliver information for the intended audience. You will learn how to write clear and readable documents, and how to revise and refine your own and others' writing. The course provides an overview of sound grammatical conventions, addresses problematic areas of the English language, and affords opportunities to address specific language issues. 
Session Highlights: 
  • Provide information on the various documents within the Pharmaceutical Manufacturing Industry 
  • Discuss the format of various documents within the Pharmaceutical Manufacturing industry 
  • Discuss the concepts the writer must keep in mind when writing a technical document 
  • Discuss any regulatory requirements and what regulatory bodies are looking for when reviewing technical documents 
  • Why the review process is important 
  • Provide examples of documents reviewed by regulatory bodies and discuss key points of those documents. 
Why You Should Attend: 
  • The reader will have a better understanding of the various documents required for the Pharmaceutical Manufacturing industry. 
  • The reader will be able to apply the concepts learned and implement it into their style of writing 
  • The course will provide an overview of the common documents seen within the industry 
  • Will provide guidelines when reviewing documents for the industry 
Who Should Attend: 
  • Personnel introduced to writing documents 
  • Subject matter experts 
  • QA personnel 
  • Personnel in manufacturing, Validation 
  • Quality Control 
  • Quality Assurance who are responsible for writing or reviewing documents 

Ask your question directly from our expert during the Q&A session following the live event.

Comments

Post a Comment

Popular posts from this blog

Construction Risk Management with Current Issues & Real Life Examples

Construction projects entail considerable risk. Profit margins are relatively low when compared to the investment made, and often estimates of cost can only be based on best guesses. Therefore, it is critical to manage and minimize the exposure to risk. Fortunately, there are several opportunities in the life of a project that allow for significant risk management . These opportunities start with the decision of whether or not to bid, and following through to the bidding, subcontracting, and management phases. In this webinar Expert Speaker Fritz Marth will explore the risk management strategies that can be employed at the various times, and in the various aspects, of a construction project. Using real-life examples, Speaker will also explore the successful implementation of these methods, as well as instances where a failure to manage risk resulted in unsuccessful outcomes. Session Highlights:  Assessing whether or not to bid a project Developing an adequate bid Properly p
Read more
Overview of  FDA computer system  validation requirements, including 21 CFR Part 11 compliance FDA requires that all computer systems that handle data regulated by the Agency to be validated in accordance with their guidance on computerized systems. This guidance was first issued in 1983, and the main points of focus remain consistent today, despite the number of years that have passed and the technology changes that have taken place. The guidance was revisited for its application to the medical device industry, as the first issuance addressed pharmaceuticals. In 1997, 21 CFR Part 11 was issued to address electronic records and signatures, as many laboratories and other FDA-regulated organizations began seeking ways to move into a paperless environment. This guidance has been modified over the years to make it more palatable to industry, and this includes discretionary enforcement measures. The intent was to avoid creating a huge regulatory compliance cost to industry that was in
Read more